From: Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma
Protein target
Signal
SEM (%)
(% of control)
CDC25C (p-S216)
39.80 %
2
CDKN1 (p-T145)
41.90 %
3.9
MEF2A (p-S408)
44.70 %
1.9
MEF2D (p-S444)
45.10 %
0.5
MEF2A (p-T312)
54.50 %
7.4